BUZZ-Australia's Neuren Pharma hits over 3-month high on $32 mln share buyback ** Shares of Neuren Pharmaceuticals NEU.AX rise as much as 8.4% to A$17.940, their highest since Aug. 5
** Stock biggest pct gainer on the benchmark S&P/ASX 200 index .AXJO
** Drug manufacturer announces commencement of on-market share buyback programme of up to A$50 mln ($32.47 mln)
** Says will buy up to 3 mln shares at A$16.540 per share, based on the last close of Wednesday
** Stock down 33.8% YTD
($1 = 1.5401 Australian dollars)
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments